Titan Pharma (TTNP) Misses Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Titan Pharma (TTNP) Misses Q4 EPS by 1c

Titan Pharmaceuticals Reports Full Year and Fourth Quarter 2015 Financial Results

March 15, 2016 7:00 AM EDT

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 03/15/16 -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura" long-term, continuous drug delivery platform, today reported financial results for the full year and fourth quarter of 2015.

Total revenues for the full year ended Dec. 31, 2015 were approximately $1.7 million, compared with approximately $3.6 million in 2014, both reflecting the amortization of the upfront license fee received from commercialization partner Braeburn Pharmaceuticals, Inc. in December 2012.

Total operating... More